Publications by authors named "Jesus Perez Martin"
Article Synopsis
- This study evaluates nirsevimab, a monoclonal antibody, for preventing respiratory syncytial virus (RSV) infections in infants under ten months in Spain.
- It involved a large immunization campaign where infants born after April 1, 2023, received nirsevimab either at birth or through a catch-up program.
- Results showed nirsevimab had an overall effectiveness of 75.8% and 80.2% in the catch-up group, highlighting its role in reducing RSV-related illnesses in primary care settings.
In 2019, ACWY meningococcal vaccination for people born between 2001 and 2007 was recommended. In Murcia, during the first 9 months, the coverage was 52.89%.
View Article and Find Full Text PDFAssociation between family structure, parental smoking, friends who smoke, and smoking behavior in adolescents with asthma.
ScientificWorldJournal
January 2010
Recent investigations show that the smoking prevalence among asthmatic adolescents is higher than among healthy adolescents, and the causes that lead these asthmatic adolescents to smoke are unclear. We investigated the association between family structure, parental smoking, smoking friends, and smoking in asthmatic adolescents (n = 6,487). After adjusting for sex and age, logistic regression analyses showed that nonintact family structure, parental smoking, and smoking friends are associated with smoking in adolescents with and without asthma.
View Article and Find Full Text PDFBackground: Allergic rhinitis, conjunctivitis and urticaria are very frequent diseases during childhood and adult age. Second generation H1 antihistamine drugs are considered first-line treatment due to their efficacy and safety.
Objective: To assess the efficacy and adverse effects of mequitazine in the treatment of these diseases.
Objective: To determine the effect of allergic rhinitis (AR), asthma, rhinobronchitis (ARB) on dental malocclusion in adolescents.
Method: This is a cross-sectional, observational, retrospective and sample descriptive study of 2556 adolescents aged 14-20 years. AR, asthma and ARB were defined by self-reported.
Aims: Allergic rhinitis is a very frequent inflammatory disease of nasal mucosa that warranties its symptomatic treatment.
Objective: To evaluate the therapeutic effect of the mequitazine in the treatment of patient with allergic rhinitis and conjunctivitis symptoms, the grade of the physician and patient satisfaction, as well as the quality of life and the side effects of the treatment.
Patients And Method: Clinical multicentric, open, longitudinal study made in the Mexican Republic with patients from 3 to 18 years of age and 113 doctors.
Objective: To determine the association among meconium aspiration syndrome, parental atopy and asthma symptoms in children younger than two years.
Material And Methods: One hundred thirty six children who had suffered meconium aspiration syndrome were followed from birth to they were two years old. CONTROL GROUP included 136 healthy children without meconium aspiration syndrome.
Objective: To assess the clinical efficacy of mequitazina in the relieve of symptoms of allergic rhinoconjunctivitis.
Patients And Methods: An open, non comparative, national multicenter study (performed by pediatricians, oto-rhino-laryngologists and allergists of different states of Mexico), in order to describe the clinical experience related to treatmente efficacy with oral mequitazina in pediatric formulation about diminished characteristic symptoms of allergic rhinitis, assessed by the physician and patient.
Results: Physicians considered that efficacy was excellent in 42% of patients, very good in 38%, good in 16%, regular in 3% and bad in 0.